[A case of acute renal failure due to interstitial nephritis likely induced by rabeprazole]. 2011

Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D009395 Nephritis, Interstitial Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction. Interstitial Nephritis,Nephritis, Tubulointerstitial,Tubulointerstitial Nephritis,Interstitial Nephritides,Nephritides, Interstitial,Nephritides, Tubulointerstitial,Tubulointerstitial Nephritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D053799 2-Pyridinylmethylsulfinylbenzimidazoles Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS. 2-Methylpyridine 2-Benzimidazole Sulfoxides,2-Pyridinylmethylsulfinyl-2-Benzimidazoles,Benzimidazole Methylpyridine Sulfoxides,Timoprazole Derivatives,Timoprazoles,2 Methylpyridine 2 Benzimidazole Sulfoxides,2 Pyridinylmethylsulfinyl 2 Benzimidazoles,2 Pyridinylmethylsulfinylbenzimidazoles,2-Benzimidazole Sulfoxides, 2-Methylpyridine,Methylpyridine Sulfoxides, Benzimidazole,Sulfoxides, 2-Methylpyridine 2-Benzimidazole,Sulfoxides, Benzimidazole Methylpyridine
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute
D064750 Rabeprazole A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt,2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole,Aciphex,Dexrabeprazole,E 3810,E3810,LY-307640,LY307640,Pariet,Rabeprazole Sodium,LY 307640,Sodium, Rabeprazole

Related Publications

Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
November 1982, The Journal of the Association of Physicians of India,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
October 2008, La Revue de medecine interne,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
February 2005, Nephrology (Carlton, Vic.),
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
May 1979, British medical journal,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
January 1989, Nephron,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
January 1976, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
April 1988, Scottish medical journal,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
January 2013, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
November 1992, Nihon Jinzo Gakkai shi,
Tomoko Iwamoto, and Yasuko Yabuki, and Masaki Hara, and Taku Morito, and Asuka Okaniwa, and Tetsuo Nemoto, and Minoru Ando
October 1984, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Copied contents to your clipboard!